Tequin Lawyers
When placed on the market by Bristol-Myers Squibb in 1999, Tequin® was promoted as a new and effective antibiotic for the treatment of lung, sinus and urinary tract infections as well as certain sexually transmitted diseases, including gonorrhea.
Bristol-Myers Squibb claims the decision to stop making Tequin® was based on "marketing reasons," but the evidence suggests a broad range of health problems strongly linked to the drug. In addition to increased risk factors involving tendon ruptures, hypoglycemia, and hyperglycemia, Tequin® has been linked to serious adverse side effect risks, which include severe and sometimes fatal allergic reactions, dangerous diarrhea, cardiovascular complications, and central nervous system side effects such as seizures and psychosis.
Frequently Asked Questions
-
What is Bextra?
Bextra (Valdecoxib) is similar to Celebrex (Celecoxib) in the respect that it is a prescription COX-2 selective inhibitor nonsteroidal anti-inflammatory drug (NSAID) used for the relief of pain …
more
-
What is the COX enzyme?
The cyclooxygenase (COX) enzyme has two forms: COX-1 and COX-2. COX-1 is found in a lot of cells all the time, notably the lining of the stomach where it regulates acid production. COX-2 is not …
more
-
What are NSAIDs?
NSAIDs are a large group of drugs that have pain-relieving (analgesic) and fever-reducing (antipyretic) effects, as well as the effect of reducing inflammation when used over time. The …
more
-
Is Bextra right for me?
You should not take Bextra if you: • Had asthma, hives or allergic reactions after taking aspirin or other NSAIDs (nonsteroidal anti-inflammatory drugs) or COX-2 inhibitors. Some …
more
-
What should I tell my health care provider?
Tell your health care provider if you: • have heart problems or high blood pressure; • have liver or kidney problems; • have or had stomach ulcers or stomach …
more
